web analytics

Management Team

Chief Executive Officer
David Williams, PhD

David is a successful entrepreneurial leader in the biopharmaceutical sector steering scientific thinking, developing financially viable businesses and creating value from collaborations and product licensing. With extensive scientific, business development, finance, and operational experience obtained from over 30 years’ experience in large Pharma and Biotech, he has been actively involved in all stages of research from target discovery and translational research through to market. continue reading...

Chief Scientific Officer
John Wain

John is Professor of Medical Microbiology at the University of East Anglia, Norwich. He spent seven years with the South East Asian Oxford University Clinical Research Unit studying genetic diversity in antibiotic resistant bacteria, four years at Imperial College, London and five at the Sanger Institute working on the translation of basic science research into public health-relevant tools. continue reading...

Chief Financial Officer
Giorgio Reggiani

Giorgio was finance Director at Stem Cell Sciences PLC, finance Director at Sareum, a founding Partner and CFO of Esprit Capital Partners, CFO at Vidus, which he helped to spin-out of British Telecom and then grow to sell for $60m, continue reading...

Director of Research
Nawaz Khan, PhD

Nawaz has extensive industrial experience with a proven track record in managing multi-disciplinary drug discovery teams.
continue reading...

Director of Biology
Clive Mason, PhD

Clive is an experienced drug discovery and biotechnology professional with technical expertise in molecular biology and biochemistry. continue reading...

Financial Controller
Jennifer Roberts

Jennifer has over 25 years’ wide-ranging accounting experience in a variety of companies especially in the Biotechnology sector including Acambis, Cambridge Biotechnology and Proximagen continue reading...

Latest Tweets from @DiscuvaLtd

Discuva Ltd @DiscuvaLtd
“We are losing the battle to control #gonorrhoeahttps://t.co/z4Fg7gd8Oj
Discuva Ltd @DiscuvaLtd
RT @SIDPharm: Whoa. 🔬🔬🔬FDA launches new website and process for susceptibility testing interpretive criteria. FDA will update the informati…
Discuva Ltd @DiscuvaLtd
RT @BIA_UK: Check out our latest blog 'Brexit and Trade – Implications for the Life Sciences Sector' by our Policy and Public Affairs Execu…